Introduction Since 2015, the World Health Organization ( WHO ) has recommended that all
people living with HIV ( PLHIV ) initiate antiretroviral treatment ( ART ), irrespective of CD 4+ …

Background Hepatitis C virus (HCV) genotype 4 non-a/d subtypes, which frequently have
NS5A resistance-associated substitutions, are highly prevalent in sub-Saharan Africa. These …

Background Hepatitis C virus (HCV) genotype 4 is the predominant type of HCV found in
sub-Saharan Africa. Various genotype 4 subtypes, such as 4r, frequently have resistance-…

Background Tungiasis is a relatively frequent ectoparasitosis in low-income settings, yet its
morbidity and social impact are still not well understood due to the scarcity of information. In …

BACKGROUND: High-risk human papillomavirus (hrHPV) may cause more than 99% of
cervical cancers worldwide. Little is known about performance differences in tests for hrHPV …

Introduction The optimal method(s) for screening HIV-infected women, especially for those
living in sub-Saharan Africa, for cervical precancer and early cancer has yet to be established…

Background Coronavirus disease 2019 (COVID-19) is a highly infectious disease with significant
mortality, morbidity, and far-reaching economic and social disruptions. Testing is key in …

Background We examined the trend in prevalence of high-risk human papillomavirus (hrHPV)
cervical infection among Rwandan women living with HIV (WLWH) over 12 years. …

Background Persistent infection with high-risk human papillomavirus (hrHPV) is a critical
step in cervical carcinogenesis. We report on type-specific hrHPV persistence, clearance and …

Introduction The AmpFire HPV genotyping Assay (Atila Biosystems, Mountain View, CA, USA)
is a new test for which there are few data regarding its analytic performance and reliability. …